influenza

Documents about influenza

• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral™ (2013-2014 Season) in Adults Aged 18 Years and Older#18677ClinicalTrials.gov
• Patient Portal Flu Vaccine Reminders_RCT 4#18678ClinicalTrials.gov
• Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children#18689ClinicalTrials.gov
• A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above#18712ClinicalTrials.gov
• A Phase III, Open-Label, Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral® Vaccine#18717ClinicalTrials.gov
• Sinovac, Pandemic Influenza A/H1N1 Vaccine in 6 to 35 Months Infants#18722ClinicalTrials.gov
• Safety of Synbiotics as Adjuvant to Influenza Vaccine in Elderly#18725ClinicalTrials.gov
• Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients#28396ClinicalTrials.gov
• A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults#28409ClinicalTrials.gov
• Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season.#28419ClinicalTrials.gov
• Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England#28425ClinicalTrials.gov
• Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine for the Elderly#28429ClinicalTrials.gov
• Safety of LAIV4 in Children With Asthma#67669ClinicalTrials.gov
• One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis.#67686ClinicalTrials.gov
• Dose, Safety, Tolerability and Immunogenicity of an Influenza H10 Stabilized Stem Ferritin Vaccine, VRC-FLUNPF0103-00-VP, in Healthy Adults#67697ClinicalTrials.gov
• A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.#121380ClinicalTrials.gov
• Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults#121429ClinicalTrials.gov
• To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years#121434ClinicalTrials.gov
• A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza#121435ClinicalTrials.gov
• A Randomized, Controlled Trial on the Efficacy and Safety of Live-Attenuated Influenza Vaccine (LAIV) Among Children in Bangladesh#121445ClinicalTrials.gov
• Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season#123534ClinicalTrials.gov
• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia#325325ClinicalTrials.gov
• A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old#329565ClinicalTrials.gov
• Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects#329566ClinicalTrials.gov
• Safety, Tolerability and Immunogenicity of NBP607QIV in Healthy Adult Volunteers#329583ClinicalTrials.gov
• Recombinant Influenza Vaccination in U.S. Nursing Homes#332804ClinicalTrials.gov
• Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects#332810ClinicalTrials.gov
• Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children#343682ClinicalTrials.gov
• Influenza Vaccine in HIV#343687ClinicalTrials.gov
• Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children#346961ClinicalTrials.gov
• Phase IV Clinical Trial of an Influenza Split Vaccine Anflu#346990ClinicalTrials.gov
• Influenza Vaccine in Premature Infants#350008ClinicalTrials.gov
• Influenza Vaccine Postpartum Questionnaire#350021ClinicalTrials.gov
• A Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu Strain#353301ClinicalTrials.gov
• A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza#353307ClinicalTrials.gov
• Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older#353339ClinicalTrials.gov
• Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S.#353340ClinicalTrials.gov
• Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults#356536ClinicalTrials.gov
• Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures#363666ClinicalTrials.gov
• The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine#363668ClinicalTrials.gov
• Expert opinion on improving influenza vaccination coverage rate in Qatar: Strategic solutions and role of live attenuated influenza vaccine (LAIV)#4634Europe PMC
• Influenza vaccine-specific CD4+ T cell responses are impaired in older adults#7750HAL (France)

Related topics